Oragenics, Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-20
Interim MD&A - English.pdf
Results 2026-05-20
Interim financial statements/report – English.pdf
News 2026-04-13
Oragenics, Inc. Announces First Patient Dosed in Phase IIa Clinical Trial Evaluating ONP-002 for Concussion and Mild Traumatic Brain Injury
News release - English.pdf
Results 2026-03-17 Financials
Annual information form - English.pdf
Results 2026-03-17 Financials
Annual MD&A - English.pdf
Results 2026-03-17 Financials
Audited annual financial statements – English.pdf
News 2026-03-11
Oragenics, Inc. Announces Completion of First Site Initiation Visit for Phase IIa Clinical Trial of ONP-002 in Australia
News release - English.pdf
News 2025-11-12
Other.pdf
Results 2025-11-07 Financials
Interim MD&A - English.pdf
Results 2025-11-07 Financials
Interim financial statements/report – English.pdf
News 2025-10-21
News release - English.pdf
News 2025-09-02
Other.pdf
News 2025-08-11
Other.pdf
Results 2025-08-08 Financials
Interim financial statements/report – English.pdf
Results 2025-08-08 Financials
Interim MD&A - English.pdf
News 2025-07-02
Material change report - English.pdf
News 2025-06-30
Other securityholders documents - English.pdf
News 2025-06-23
Other.pdf